Is there a target for treatment for heart failure with reduced ejection fraction?

Dr Januzzi: For chronic heart failure with reduced ejection fraction, the target is less than 1000  pg/mL. Below a 1000 pg/mL value, indicates ventricular remodelling begins to improve. That would be the target for chronic ambulatory heart failure.

For inpatient heart failure management, there is a wide range of values in patients that are hospitalised. 30% change is the biological variation of NT-proBNP. In the inpatient setting, due to lack of time, NT-proBNP values below a 1000 pg/mL are difficult to obtain, but a 30% reduction is considered a good sign. In the office or outpatient setting an absolute hard target of 1000 pg/mL and below is recommended.

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy. [...]

Read...

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi